Group 1 - The company plans to issue shares to specific investors, raising a total of no more than 319,900,007.18 yuan, which will be used to repay entrusted loans from China Research [2][3][48] - The issuance aims to convert state-owned capital funds into direct equity investment, thereby optimizing the company's capital structure and reducing financial costs [3][5][48] - The issuance will lower the company's debt-to-asset ratio from 33.02% to 28.26%, enhancing its financial stability [6][9][48] Group 2 - The company has established a modern corporate governance structure and internal control environment to ensure the proper use of raised funds [8][21] - The company will utilize the raised funds to repay entrusted loans, which will reduce interest expenses by approximately 6.5 million yuan annually, thereby increasing profitability [6][10][49] - The company has committed to enhancing its profit distribution policy and investor return mechanisms to mitigate the dilution of immediate returns from the share issuance [20][23][24] Group 3 - The issuance involves a related party transaction with the controlling shareholder, China Research, which will subscribe to the shares at an adjusted price of 7.05 yuan per share [28][31][45] - The company has received necessary approvals from its board and shareholders for the issuance, ensuring compliance with regulatory requirements [52][53] - The company aims to strengthen its capital base and improve its operational efficiency through this share issuance, ultimately maximizing shareholder value [48][49]